Literature DB >> 24264010

Prevalence of systemic lupus erythematosus and risk factors in rural areas of Anhui Province.

Yan-Feng Zou1, Chen-Chen Feng, Ji-Min Zhu, Jin-Hui Tao, Gui-Mei Chen, Qian-Ling Ye, Han Cen, Rui-Xue Leng, Fa-Ming Pan, Hai-Feng Pan, Rui Li, Yin-Guang Fan, Bin Wang, Xiang-Pei Li, Feng-Yu Zhang, Dong-Qing Ye.   

Abstract

Systemic lupus erythematosus (SLE) is a severe complex rheumatic disease, but good estimate of its prevalence and risk factors is lacking in China. The aim of the study was to explore the prevalence of SLE and risk factors in rural areas of Anhui Province of China. Eleven counties were randomly selected in Anhui Province, and then, 15% of the villages in selected counties were randomly sampled as study sites. Patients with SLE were identified through two phases. Based on the cases identified, a population-based case-control study was designed to examine risk factors associated with SLE. A total of 1,253,832 individuals and identified 471 SLE cases were surveyed. Crude and age-standardized prevalence were estimated at 37.56 and 36.03 per 100,000 persons, respectively. Gender difference in the prevalence of SLE was significant (P = 4.62 × 10(-76)), and the age-standardized prevalence was 6.17 for males and 67.78 for females per 100,000 persons. The distribution of SLE prevalence was significant by age group (P = 1.78 × 10(-53)), and the peak prevalence was observed at 40-50 years. Multiple environmental factors were associated with SLE, including birth conditions, sweet food, cooking oil, taste, fruit consumption, sunlight exposure, quality of sleep, physical activities, drinking water, residence, negative life events, hepatitis B vaccine, age of menarche, and age at birth of first child (P < 0.05). Our large population-based epidemiological survey estimated the prevalence of SLE at 37.56 per 100,000 persons. Multiple environmental factors were associated with the development of SLE.

Entities:  

Mesh:

Year:  2013        PMID: 24264010     DOI: 10.1007/s00296-013-2902-1

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  26 in total

1.  Nationwide population-based epidemiologic study of systemic lupus erythematosus in Taiwan.

Authors:  Y-M Chiu; C-H Lai
Journal:  Lupus       Date:  2010-07-20       Impact factor: 2.911

2.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

Review 3.  The epidemiology of systemic lupus erythematosus.

Authors:  M Siegel; S L Lee
Journal:  Semin Arthritis Rheum       Date:  1973       Impact factor: 5.532

4.  [Influences of environmental factors and interaction of several chemokines gene-environmental on systemic lupus erythematosus].

Authors:  Dong-qing Ye; Yi-song Hu; Xiang-pei Li; Fen Huang; Shi-gui Yang; Jia-hu Hao; Jing Yin; Guo-qing Zhang; Hui-hui Liu
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2004-11

5.  Epidemiology and survival of systemic lupus erythematosus in Hong Kong Chinese.

Authors:  C C Mok
Journal:  Lupus       Date:  2010-12-10       Impact factor: 2.911

Review 6.  Environmental epidemiology and risk factors for autoimmune disease.

Authors:  M A Dooley; S L Hogan
Journal:  Curr Opin Rheumatol       Date:  2003-03       Impact factor: 5.006

7.  Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus.

Authors:  R Cervera; M A Khamashta; J Font; G D Sebastiani; A Gil; P Lavilla; I Doménech; A O Aydintug; A Jedryka-Góral; E de Ramón
Journal:  Medicine (Baltimore)       Date:  1993-03       Impact factor: 1.889

Review 8.  Understanding the epidemiology and progression of systemic lupus erythematosus.

Authors:  Guillermo J Pons-Estel; Graciela S Alarcón; Lacie Scofield; Leslie Reinlib; Glinda S Cooper
Journal:  Semin Arthritis Rheum       Date:  2009-01-10       Impact factor: 5.532

Review 9.  The epidemiology of systemic lupus erythematosus.

Authors:  Sònia Jiménez; Ricard Cervera; Josep Font; Miguel Ingelmo
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

Review 10.  The geoepidemiology of systemic lupus erythematosus.

Authors:  Andrea T Borchers; Stanley M Naguwa; Yehuda Shoenfeld; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2009-12-24       Impact factor: 9.754

View more
  11 in total

Review 1.  The global burden of SLE: prevalence, health disparities and socioeconomic impact.

Authors:  Erin E Carter; Susan G Barr; Ann E Clarke
Journal:  Nat Rev Rheumatol       Date:  2016-08-25       Impact factor: 20.543

2.  Risk factors for 1-year hospital readmissions in patients with systemic lupus erythematosus.

Authors:  Jinxia Chen; Limin Zhang; Liutao Huang; Shuxian Chen; Yongzhi Xu; Huafeng Liu
Journal:  Clin Exp Med       Date:  2022-05-27       Impact factor: 3.984

3.  Proteomic Analyses Reveal Higher Levels of Neutrophil Activation in Men Than in Women With Systemic Lupus Erythematosus.

Authors:  Ming-Long Cai; Lan Gui; He Huang; Yu-Kun Zhang; Li Zhang; Zhu Chen; Yu-Jun Sheng
Journal:  Front Immunol       Date:  2022-06-21       Impact factor: 8.786

4.  Establishing a reference interval for serum anti-dsDNA antibody: A large Chinese Han population-based multi-center study.

Authors:  Chuiwen Deng; Shulan Zhang; Chaojun Hu; Ping Li; Ziyan Wu; Si Chen; Jing Li; Liubing Li; Fengchun Zhang; Yongzhe Li
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240

5.  The Possible Effect of B-Cell Epitopes of Epstein-Barr Virus Early Antigen, Membrane Antigen, Latent Membrane Protein-1, and -2A on Systemic Lupus Erythematosus.

Authors:  Jianxin Tu; Xiaobing Wang; Guannan Geng; Xiangyang Xue; Xiangyang Lin; Xiaochun Zhu; Li Sun
Journal:  Front Immunol       Date:  2018-02-12       Impact factor: 7.561

6.  Effects of transitional care on self-care, readmission rates, and quality of life in adult patients with systemic lupus erythematosus: a randomized controlled trial.

Authors:  Xia Xie; Yuqing Song; Hui Yang; Anliu Nie; Hong Chen; Ji-Ping Li
Journal:  Arthritis Res Ther       Date:  2018-08-16       Impact factor: 5.156

7.  Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus.

Authors:  Richard A Furie; Ian N Bruce; Thomas Dörner; Manuel Gustavo Leon; Piotr Leszczyński; Murray Urowitz; Birgit Haier; Teri Jimenez; Claire Brittain; Jiajun Liu; Catherine Barbey; Christian Stach
Journal:  Rheumatology (Oxford)       Date:  2021-11-03       Impact factor: 7.046

8.  Risk perceptions of drinking bottled vs. tap water in a low-income community on the US-Mexico Border.

Authors:  Kerton R Victory; Amanda M Wilson; Nolan L Cabrera; Daniela Larson; Kelly A Reynolds; Joyce Latura; Paloma I Beamer
Journal:  BMC Public Health       Date:  2022-09-09       Impact factor: 4.135

Review 9.  Global epidemiology of systemic lupus erythematosus.

Authors:  Megan R W Barber; Cristina Drenkard; Titilola Falasinnu; Alberta Hoi; Anselm Mak; Nien Yee Kow; Elisabet Svenungsson; Jonna Peterson; Ann E Clarke; Rosalind Ramsey-Goldman
Journal:  Nat Rev Rheumatol       Date:  2021-08-03       Impact factor: 32.286

Review 10.  Gender differences in ocular blood flow.

Authors:  Doreen Schmidl; Leopold Schmetterer; Gerhard Garhöfer; Alina Popa-Cherecheanu
Journal:  Curr Eye Res       Date:  2014-06-03       Impact factor: 2.424

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.